Cargando…
P1658: DELAYED REVERSAL OF FACTOR V INHIBITOR ACTIVITY POST-IMMUNOSUPPRESSIVE THERAPY, FOLLOWED BY A SUCCESSFUL PREGNANCY: A CASE REPORT
Autores principales: | Cegledi, A., Bodo, I., Dolgos, J., Varkonyi, A., Vilimi, B., Mikala, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429423/ http://dx.doi.org/10.1097/01.HS9.0000849488.34758.87 |
Ejemplares similares
-
Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement
por: Ceglédi, Andrea, et al.
Publicado: (2023) -
1658. Particularities Of Pulmonary Tuberculosis Among Children
por: Hammami, Fatma, et al.
Publicado: (2020) -
Dalcetrapib: JTT 705; JTT-705; R 1658; R1658; RG1658; RO 4607381; RO4607381
Publicado: (2012) -
P1658: CLINICAL CHARACTERISTICS OF A HIGH-POSITIVE ANTIPHOSPHOLIPID SYNDROME
por: Khoduleva, Sviatlana, et al.
Publicado: (2023) -
Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen
por: Simon, Barbara, et al.
Publicado: (2022)